CME Presentations

Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the National Breast Cancer Foundation.

ACKNOWLEDGEMENT

This activity has been supported by an independent educational grant from Gilead Sciences, Inc.

DATE OF RELEASE/EXPIRATION

This activity was released on June 29, 2023 and is valid until June 29, 2024. Requests for credit must be made no later than June 29, 2024.

TARGET AUDIENCE

The educational design of this activity addresses the needs of medical oncologists, pathologists, nurse practitioners, physician assistants, nurses, and other HCPs managing patients with triple-negative breast cancer (TNBC).

STATEMENT OF NEED/PROGRAM OVERVIEW

Despite recent advances, triple-negative breast cancer (TNBC) remains difficult to treat due to a poor prognosis and a small number of effective treatments. Thus, clinicians’ priorities need to be aligned with patient goals and perspectives to ensure optimal care and overcome patient misunderstandings about treatment and clinical-trial options.

Join an expert panel of oncologists and oncology nurse practitioners for an in-depth discussion of patient-centered care practices for TNBC that incorporate and align with patient preferences for treatment. Panelists will also discuss effective strategies for TNBC management and appropriate incorporation of novel therapies into treatment regimens. Do you have patients who have been diagnosed with TNBC who could use education on treatment options, clinical trials, and available support resources? Direct your patients to MedLive.com to access the activity, “Navigating Treatment and Support for Triple-Negative Breast Cancer.”

Do you have patients who have been diagnosed with TNBC who could use education on treatment options, clinical trials, and available support resources? Direct your patients to MedLive.com to access the activity, “Navigating Treatment and Support for Triple-Negative Breast Cancer.”

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Describe current and emerging treatment approaches for TNBC, especially second-line treatments and strategies for advanced/metastatic TNBC
• Incorporate processes for addressing and aligning perspectives with patients throughout the care process for
• Discuss real-world data describing patient gaps, disparities, and perspectives regarding involvement in clinical trials

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION

PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

FACULTY AND DISCLOSURE OF CONFLICTS OF INTEREST

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty	Conflicts of Interest
Tiffany A. Traina, MD, FASCO Vice Chair, Department of Medicine Associate Attending Physician Breast Medicine Service Memorial Sloan Kettering Cancer Center Associate Professor of Medicine Weill Cornell Medicine	Consultant, Advisor, Speaker: Agendia, AstraZeneca, Blueprint Medicines, bioTheranostics, Daiichi Sankyo, Ellipses Pharma, Fuji Pharma, G1 Therapeutics, GE Healthcare, Genentech/Roche, Gilead Sciences, GlaxoSmithKline, Hengrui Pharmaceuticals, Infinity, Iteos Therapeutics, Merck, Novartis, Pfizer, SeaGen, TerSera Researcher: Astellas Pharma, AstraZeneca, Ayala Pharm, Carrick Pharma, Daiichi Sankyo, Genetech/Roche, Immunomedics, Innocrin Pharma, Pfizer
Gregory Vidal, MD, PhD Associate Professor University of Tennessee Health Science Center Director of Clinical Research West Cancer Center & Research Institute Chair, Breast Oncology Program, One Oncology	Consulting Fee: Roche/Genetech, Novartis, Eli Lilly, Gilead, Puma, Pfizer, AstraZeneca, Biotheranautics, Daiichi Sankyo, Concerto AI, Stemline, Gilead Research: Roche/Genetech, Puma, Celcuity, Merck, BMS, Eli Lilly, Astrazeneca, Pfizer, Gilead, GlaxoSmithKline, Novartis, Tesaro, Napo Pharmaceuticals Ownership: Oncodisc
Stephanie Walker, RN MBC Thriver and Advocate Patient Advisor The BECOME Project	No relevant financial relationships to disclose

The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For additional information about the accreditation of this activity, please visit https://partnersed.com.

Technical Support:

For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the National Breast Cancer Foundation, Inc. (NBCF), and Touch, The Black Breast Cancer Alliance (TOUCH).

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Gilead Sciences, Inc.

DATE OF LIVE ACTIVITY

Friday, April 22, 2022 from 12:00 – 1:00pm ET

TARGET AUDIENCE

The educational design of this activity addresses the needs of medical oncologists, pathologists, pharmacists, nurse practitioners, physician assistants, nurses, and other HCPs managing patients with TNBC.

STATEMENT OF NEED/PROGRAM OVERVIEW

Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer, disproportionally affecting young Black women. In addition, women from racial minorities tend to be diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. While standard chemotherapy has a high rate of failure in patients with TNBC, first-in-class targeted therapies offer hope of a more effective treatment for patients.

Join a distinguished panel of expert oncologists to explore how disparities in care negatively affect racial minority patients with TNBC, and the necessary steps healthcare professionals can take to address these inequities. Panelists will discuss how health care professionals can formulate plans to screen and diagnose these patients earlier and include genetic counselors on care teams to support patients after diagnosis. Experts will also review the evolving TNBC treatment landscape, the safety and efficacy of the newly approved anti-TROP-2, and additional agents under investigation.

Can your patients benefit from related education on the recognition and treatment of TNBC? Direct your patients to CancerCoachLive.com to access the patient-education activity, “Facing TNBC: Self-Advocacy and Decision-making.”

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

• Discuss solutions to address disparities in care for women of ethnic minorities diagnosed with TNBC
• Review recent advances in TNBC pathogenesis and prognosis
• Coordinate referrals to genetic testing and counseling
• Evaluate the mechanisms of action and safety and efficacy data for current and emerging TNBC agents
• Facilitate patient-centered care through accounts of real-world patient experiences

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Name of Faculty or Presenter	Reported Financial Relationship
Tiffany A. Traina, MD Vice Chair, Oncology Care Section Head Triple Negative Breast Cancer Clinical Research Program Associate Attending Physician Breast Medicine Service Memorial Sloan Kettering Cancer Center Associate Professor Weill Cornell Medical College	Consulting Fee (e.g., Advisory Board): Agendia, AstraZeneca, Athenex, Ayala Pharmaceuticals, Blueprint Medicines, Daiichi Sankyo, Eisai, Ellipses Pharma, Exact Sciences, Foundation Medicine, Fuji Pharma, Genentech/Roche, Gilead Sciences, Ionis, Iteos Therapeutics, Merck, Pfizer, Puma Biotechnology, Seattle Genetics Contracted Research - Paid to Institution: AstraZeneca, Astellas Pharma, Ayala Pharmaceuticals, Carrick Pharm, Daiichi Sankyo, Eisai, Genentech/Roche, Innocrin Pharma, Immunomedics, Novartis, Pfizer
Lori L. Wilson, MD Associate Dean of Faculty Affairs, COM Division Chief, Surgical Oncology Chief of Breast Oncology Howard University Hospital and College of Medicine	Nothing to disclose

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager	Reported Financial Relationship
Rhys Williams, RN, MSN, FNP	Nothing to disclose
Lindsay Borvansky	Nothing to disclose
Andrea Funk	Nothing to disclose
Liddy Knight	Nothing to disclose
Ashley Cann	Nothing to disclose
Jaimee Harris-Gold	Nothing to disclose
Colleen Heffner	Nothing to disclose
Tariqa Ackbarali	Nothing to disclose
Juliet Copeland - Patient Participant	Nothing to disclose
Nicki Davis - Patient Participant	Nothing to disclose
Barbara Kaye - Patient Participant	Nothing to disclose
Yolanda Thomas - Patient Participant	Nothing to disclose

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.